We introduce the optical ruler, an electromagnetic analog of a physical ruler, for nanoscale displacement metrology. The optical ruler is a complex electromagnetic field in which singularities serve as the marks on the scale. It is created by the diffraction of light on a metasurface, with singularity marks then revealed by high-magnification interferometric observation.
View Article and Find Full Text PDFLenses are crucial to light-enabled technologies. Conventional lenses have been perfected to achieve near-diffraction-limited resolution and minimal chromatic aberrations. However, such lenses are bulky and cannot focus light into a hotspot smaller than a half-wavelength of light.
View Article and Find Full Text PDFOptical superoscillatory imaging, allowing unlabelled far-field super-resolution, has in recent years become reality. Instruments have been built and their super-resolution imaging capabilities demonstrated. The question is no longer whether this can be done, but how well: what resolution is practically achievable? Numerous works have optimised various particular features of superoscillatory spots, but in order to probe the limits of superoscillatory imaging we need to simultaneously optimise all the important spot features: those that define the resolution of the system.
View Article and Find Full Text PDFSuper-oscillation is a counterintuitive phenomenon describing localized fast variations of functions and fields that happen at frequencies higher than the highest Fourier component of their spectra. The physical implications of this effect have been studied in information theory and optics of classical fields, and have been used in super-resolution imaging. As a general phenomenon of wave dynamics, super-oscillations have also been predicted to exist in quantum wavefunctions.
View Article and Find Full Text PDFThis study was conducted to compare the clinical curative effect and acute radiation lung reactions between CyberKnife (CK) and three-dimensional conformal radiotherapy (3DCRT) treatment for inoperable stage I peripheral non-small-cell lung cancer (NSCLC). We retrospectively analyzed 68 patients with inoperable stage I peripheral NSCLC between 2012 and 2013 in our institution. The CK patients were treated with 42-60 Gy in three fractions, while the 3DCRT patients were treated with a total of 60 Gy, at 2 Gy per fraction.
View Article and Find Full Text PDFThe development of novel antitumor drugs for the treatment of non-small cell lung carcinoma NSCLC is imperative in order to improve the efficacy of lung cancer therapy and prognosis. In the current study, we demonstrated the antitumor activity of isorhamnetin and its combinations with cisplatin and carboplatin against A-549 lung cancer cells. In order to assess the anticancer enhancing effect of isorhamnetin on cisplatin and carboplatin, A-549 cells were treated with isorhamnetin, cisplatin, carboplatin and their combinations and cell viability, cell apoptosis, cell cycle arrest as well as loss of mitochondrial membrane potential were evaluated by MTT assay, flow cytometry, confocal microscopy and fluorescence microscopy.
View Article and Find Full Text PDF